当前位置:
X-MOL 学术
›
Antimicrob. Agents Chemother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
In Vitro Activity of Ceftibuten/VNRX-5236 against Urinary Tract Infection Isolates of Antimicrobial-Resistant Enterobacterales
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01304-21 James A Karlowsky 1, 2 , Meredith A Hackel 1 , Daniel F Sahm 1
Antimicrobial Agents and Chemotherapy ( IF 4.9 ) Pub Date : 2021-10-18 , DOI: 10.1128/aac.01304-21 James A Karlowsky 1, 2 , Meredith A Hackel 1 , Daniel F Sahm 1
Affiliation
Ceftibuten/VNRX-7145 is a cephalosporin/boronate β-lactamase inhibitor combination
under development as an oral treatment for complicated urinary tract infections caused
by Enterobacterales producing serine β-lactamases (Ambler class A, C and D). In vivo, ...
中文翻译:
头孢布汀/VNRX-5236 对耐药肠杆菌的尿路感染分离株的体外活性
Ceftibuten/VNRX-7145 是一种头孢菌素/硼酸盐 β-内酰胺酶抑制剂组合,正在开发用于口服治疗由产生丝氨酸 β-内酰胺酶(Ambler A、C 和 D 类)的肠杆菌引起的复杂尿路感染。在体内,...
更新日期:2021-10-20
中文翻译:
头孢布汀/VNRX-5236 对耐药肠杆菌的尿路感染分离株的体外活性
Ceftibuten/VNRX-7145 是一种头孢菌素/硼酸盐 β-内酰胺酶抑制剂组合,正在开发用于口服治疗由产生丝氨酸 β-内酰胺酶(Ambler A、C 和 D 类)的肠杆菌引起的复杂尿路感染。在体内,...